362 related articles for article (PubMed ID: 10502584)
1. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
Verbraak FD; Boom R; Wertheim-van Dillen PM; van den Horn GJ; Kijlstra A; de Smet MD
Br J Ophthalmol; 1999 Oct; 83(10):1186-9. PubMed ID: 10502584
[TBL] [Abstract][Full Text] [Related]
2. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG
Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970
[TBL] [Abstract][Full Text] [Related]
4. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
5. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.
Torriani FJ; Freeman WR; Macdonald JC; Karavellas MP; Durand DM; Jeffrey DD; Meylan PR; Schrier RD
AIDS; 2000 Jan; 14(2):173-80. PubMed ID: 10708288
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART.
Waib LF; Bonon SH; Salles AC; Benard G; de Oliveira AC; Pannuti CS; Pedro Rde J; Costa SC
Rev Inst Med Trop Sao Paulo; 2007; 49(4):215-9. PubMed ID: 17823749
[TBL] [Abstract][Full Text] [Related]
9. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.
Deayton J; Mocroft A; Wilson P; Emery VC; Johnson MA; Griffiths PD
AIDS; 1999 Jul; 13(10):1203-6. PubMed ID: 10416523
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
Reed JB; Briggs JW; McDonald JC; Freeman WR; Morse LS
Retina; 2001; 21(4):339-43. PubMed ID: 11508879
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Whitcup SM
JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
Jacobson MA; Zegans M; Pavan PR; O'Donnell JJ; Sattler F; Rao N; Owens S; Pollard R
Lancet; 1997 May; 349(9063):1443-5. PubMed ID: 9164318
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
[TBL] [Abstract][Full Text] [Related]
14. Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients.
Panagiotakis SH; Soufla G; Baritaki S; Sourvinos G; Passam A; Zagoreos I; Stavrianeas N; Spandidos DA
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):10-8. PubMed ID: 17263627
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
Casado JL; Arrizabalaga J; Montes M; Martí-Belda P; Tural C; Pinilla J; Gutierrez C; Portu J; Schuurman R; Aguirrebengoa K
AIDS; 1999 Aug; 13(12):1497-502. PubMed ID: 10465073
[TBL] [Abstract][Full Text] [Related]
16. Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.
Gerna G; Piccinini G; Genini E; Percivalle E; Zavattoni M; Lilleri D; Testa L; Comolli G; Maserati R; Baldanti F; Maccario R; Monforte AD; Revello MG
J Acquir Immune Defic Syndr; 2001 Dec; 28(4):320-31. PubMed ID: 11707667
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.
Jevtović DJ; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2005 Mar; 6(2):140-3. PubMed ID: 15807721
[TBL] [Abstract][Full Text] [Related]
18. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR
J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy.
Song MK; Schrier RD; Smith IL; Plummer DJ; Freeman WR
Retina; 2002 Jun; 22(3):262-7. PubMed ID: 12055457
[TBL] [Abstract][Full Text] [Related]
20. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2232-9. PubMed ID: 15582079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
